Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huttner, I. G.
Right arrow Articles by Nicholson, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huttner, I. G.
Right arrow Articles by Nicholson, G. A.
Related Collections
Right arrow Peripheral neuropathy
Right arrow All Genetics
NEUROLOGY 2006;67:2016-2021
© 2006 American Academy of Neurology

Proof of genetic heterogeneity in X-linked Charcot–Marie–Tooth disease

I. G. Huttner, MD, M. L. Kennerson, PhD, S. W. Reddel, MD, PhD, D. Radovanovic, BSc and G. A. Nicholson, MD, PhD

From the Northcott Neuroscience Laboratory, ANZAC Research Institute (I.G.H., M.L.K., S.W.R., G.A.N.) and Molecular Medicine Laboratory, Concord Hospital, Concord, Australia (M.L.K., S.W.R., D.R., G.A.N.).

Address correspondence and reprint requests to Professor Garth Nicholson, Molecular Medicine Laboratory, Concord Hospital, NSW 2139, Australia; e-mail: garthn{at}med.usyd.edu.au

Objective: To characterize a large family with X-linked Charcot–Marie–Tooth (CMT) neuropathy without mutations in the gap junction protein B1 (GJB1) gene, which has an unusual phenotype that is different in some aspects from classic CMTX1.

Methods: We tested CMT families consistent with X-linked inheritance for GJB1 mutations. We compared the largest family (CMT623) without GJB1 mutation and with linkage excluding the CMTX1 locus to CMTX1 and normal individuals.

Results: Only 51% of probable X-linked CMT families had mutations in GJB1. Family CMT623 shows linkage to Xq26.3-q27.1 (lod score z = 6.58), a region within the previously identified locus for CMTX3, Xq26-q28. Unlike CMTX1, affected males in family CMT623 report pain and paraesthesia before the onset of sensory loss, and women are usually asymptomatic. As in CMTX1, affected males have widely ranging intermediate motor conduction velocities. The coding regions of 14 positional candidate genes within the narrowed CMTX3 locus have been excluded for a pathogenic role in the disease.

Conclusion: This study is the first to confirm the CMTX3 locus and to refine the genetic interval to a 5.7-Mb region flanked by the markers DXS1041 and DXS8106. GJB1 mutation–negative forms of X-linked CMT, such as CMTX3, may account for a significant proportion of X-linked CMT.

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the December 12 issue to find the title link for this article.

This work was partially supported by the CMT Association of Australia and by a postdoctoral fellowship from the Deutsche Akademie der Naturforscher Leopoldina (Förderkennzeichen BMBF-LPD 9901/8-106) to I.G.H.

Disclosure: The authors report no conflicts of interest.

Received March 9, 2006. Accepted in final form August 22, 2006.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.